Studies on the SNPs and Haplotype of Cytochrome P450 gene in Tae-eum, So-yang and So-eum persons

태음인, 소양인, 소음인별 Cytochrome P450 유전자의 2D6, 2C9, 1A2 DNA 부위에 대한 SNPs과 Haplotype에 관한 연구

  • Park Jong Oh (Department of Pathology, Oriental Medical College, Taejeon University) ;
  • Lim Nam Kyoo (Pharmacodesign(Inc).) ;
  • Lee Yong Heun (Department of Statistics, Chungang University) ;
  • Chae Heui Jin (Department of Cognitive Science, Yonsei University) ;
  • Uk Namgung (Department of Pathology, Oriental Medical College, Taejeon University) ;
  • Kim Dong Hee (Department of Pathology, Oriental Medical College, Taejeon University)
  • Published : 2002.12.01

Abstract

In oriental medicine, human being is classified into four groups according to their body constitution status (;tae-yang, tae-eum, so-yang, and so-eum persons) considering the differences in function of internal organs and characteristics. Four body constitution, called 'sa-sang' has been recognized as an important factor for diagnosing the patients before madical teratment. Yet, the criteria to divide body constitutions or its scientific principle are not clearly defined. As an initial effort to elucidate biological priciples underlying four body constitution groups, we studied genetic variations among three constitution groups (tae-eum, so-yang, and so-eum persons). Noting distinct responses to ingested food and administered drugs among three groups, SNPs and haplotype experiments were performed in 2D6, 2C9, and 1A2 DNA regions of the cytochrome P450 gene. Significant variability in SNPs types was found in 2D6 region. Moreover, haplotyping in 2D6 region showed relatively high occurrences of haplotype 3 and 5 in so-eum person, haplotype 6 in tae-eum person, and hyplotype 1 in so-yang person. These results indicate that individuals with different body constitutions respond differently to ingested food and drugs, which might reflect constitution-specific genetic background. The genetic approach would therefore be useful to reveal intrinsic differences among four constitution body groups in the responsiveness to various drugs and external stimulations to human body.

Keywords

References

  1. 동의수세보원 v.서울 이제마
  2. 사상의학회지 v.4 no.6 설문지를 이용한 체질감별방법의 신뢰도에 관한 연구 김달래
  3. 사상두부촉진법 v.147 박석언
  4. 동양의학 창간호 체질의학과 체질침 권도언
  5. 대한한의학회지 v.14 희수식 맥진기를 이용한 사상체질 감별법 나경찬
  6. 대한체질인류학회지 v.13 no.4 사상체질과 신체형태지수와의 연관성. 박경아;김희진;허경석;안수경;이성호;이종은;이원택
  7. 사상의학회지 v.10 사상인의 형태학적 특징에 관한 연구 이의주;고병일;송일병
  8. 대한사상의학회지 v.5 no.1 사상체질분류검사(QSCC)의 타당화연구 김선호
  9. 동의사상의학강좌 유주열
  10. 대한사상의학회지 v.8 no.1 사상체질별 두면부의 형태학적인 특징 고병희;홍석철;송일병
  11. 정선 한국의 체질의학 경희대학교 한의과대학 제42기 졸업준비위원회
  12. 사상의학회지 v.7 적외선 체열촬영을 이용한 체질판별의 특징 파라미터의 추출. 조봉관;고병희;마사오 사이토
  13. 圖說 바이오디지탈 O-ring 테스트의 실습 大村惠昭
  14. 대한한의학회지 v.14 no.2 사상체질감별에 있어서 한약을 이용한 오링테스트 결과보고 서울 정원조
  15. 사상체질의학론 윤길영
  16. 사상의학총론 노정우
  17. Forsch Komplementarmed Klass Naturheilkd v.8 no.5 Dyspeptic pain and phytotherapy--a review of traditional and modern herbal drugs. Saller R;Iten F;Reichling J.
  18. Soc Sci Med v.47 no.6 Personal constitution and health status among Chinese elderly in Taipei and Los Angeles. Lew-Ting CY;Hurwicz ML;Berkanovic E.
  19. 의학유전학
  20. Pharmacogenomic(The Search for Individualized Therapies) Julio Licinio;Ma-Li wong.
  21. Pharmacogenomics v.2 no.1 The relative power of SNPs and haplotype as genetic markers for association tests. Bader JS.
  22. Mol. biol. Evol. Maximum- Likelihood Estimation of Molecular Haplotype Frequencies in a Diploid Population. Laurent Excoffier;Montgomery Slatkin.
  23. Pharmacogenomics v.3 no.2 Beta-adrenergic receptor polymorphisms and drug responses in asthma. Taylor DR;Kennedy MA.
  24. Proc Natl Acad Sci v.97 Complex promotor and coding region 2-adrenergic receptor haplotypes alter receptor expression and prediction in vivo responsiveness. Drysdale CM;McGraw DW;Stack CB;Stephens JC;Judson RS; Nandabalan K.
  25. 대한사상체질의학회 공식 홈페이지
  26. 대한체질인류학회지 v.12 지문과 사상체질 유형의 관계 김이석;정민석;박성식
  27. 한국한의학연구원논문집 v.5 사상체질 유형에 따른 손바닥문,손금의 특징. 정민석;김이석;박성식
  28. 경희한의대논문집 유형체질감별의 면역혈청학적 연구 양기상
  29. 한국한의학연구소논문집 2 사상의학의 객관화를 위한 유전적 분석 연구. 조동욱;이창수;고병희;홍석철;이의주;조황성
  30. 한국영양학회지 v.18 no.2 체질의학의 체질분류법에 따른 식품기호도와 영양상태의 상관성에 관한 연구 김숙희;김화영;이필자;권도원;김용옥
  31. 정선 한국의 체질의학 경희대학교 한의과대학 제42기 졸업준비위원회
  32. Drug Metab Dispos v.30 no.12 Multiple Cytochrome P450 Enzymes Responsible for the Oxidative Metabolism of the Substituted (S)-3-Phenylpiperidine,(S,S)-3-[3-(Methylsulfonyl)phenyl]-1propylpiperidine Hydrochloride, in Human Liver Microsomes. Wienkers LC;Wynalda MA.
  33. Nature genetics. v.26 Genome- wide analysis of single-nucleotide polymorphisms in human expressed sequences. Kris Irizarry;Vlad Kustanovich;Cheng Li;Nik Brown;Stanley Nelson; Wing wong;Christopher J. Lee.
  34. Genome Research. Base-Calling of Automated Sequencer Trace Using Phred. Brent Ewing;Phil Green.
  35. 黃帝內經靈樞釋解 楊維傑
  36. 사상의학회지 v.6 설문지를 이용한 체질감별방법의 신뢰도에 관한 연구 金達來
  37. 한국한의학연구소논문집 2 사상의학의 객관화를 위한 유전적 분석 연구 조동욱;이창수;고병희;홍석철;이의주;조황성
  38. 四象醫藥性理臨床論 金洲
  39. Mol. biol. Evol. Inference of Haplotype from PCR- amplified Samples of Diploid Populations. Andrew G. Clark.
  40. 사상의약성리임상론 김주
  41. 체질을 알면 건강이 보인다 이명복
  42. 의학유전학
  43. Nat Biotechnol v.18 no.5 The use of single-nucleotide polymorphism maps in pharmacogenomics. McCarthy JJ;Hilfiker R.
  44. Gan To Kagaku Ryoho v.29 no.9 SNP collection, pharmacogenomics, and the future of drug therapy. Iida A;Saito S;Sekine A;Nakamura Y.
  45. Curr Opin Drug Discov Devel v.4 no.3 The development of pharmacogenomic models to predict drug response Adam GI.
  46. Nature v.409 A map of humal genome sequence variation containing 1.42 million single nucleltide polymorphisms The International SNP Map Working Group.
  47. Nature Genet v.22 Characterization of single-nucleotide polymorphisms in coding regions of human genes. Cargill M AltshulerD;Ireland J;Sklar P Ardlie K Patil N.
  48. Drug Metab Dispos. v.30 no.12 Enantioselective metabolism of the endocrine disruptor pesticide methoxychlor by human cytochromes p450(p450s): major differences in selective enantiomer formation by various p450 isoforms. Hu Y;Kupfer D.
  49. Pharmacotherapy v.22 no.11 Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6. Ellingrod VL;Schultz SK;Arndt S.
  50. Trends Pharmacol Sci. v.23 no.11 Opposites attract, or do they? Rethinking the P450 2D6 pharmacophore model. Gillam EM.
  51. Clin Pharmacol Ther. v.72 no.5 Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes. Lee CR;Pieper JA;Hinderliter AL;Blaisdell JA;Goldstein JA.
  52. Haematologica. v.87 no.11 Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation. Tassies D;Freire C;Pijoan J;Maragall S;Monteagudo J;Ordinas A; Reverter JC.
  53. J Card Fail v.8 no.5 Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. Frye RF;Schneider VM;Frye CS;Feldman AM.
  54. Br J Pharmacol. v.137 no.6 Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators. Fradette C;Bleau AM;Pichette V;Chauret N;Du Souich P.
  55. Mutat Res. v.508 no.1-2 Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin. Takahashi E;Fujita K;Kamataki T;Arimoto-Kobayashi S;Okamoto K; Negishi T.